He, J., Siu, M. K., Ngan, H. Y. S., & Chan, K. K. L. (2021). Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets. Frontiers Media S.A.
Cita Chicago Style (17a ed.)He, Jiangnan, Michelle K.Y Siu, Hextan Y. S. Ngan, y Karen K. L. Chan. Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)He, Jiangnan, et al. Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.